ABSTRACT The primary goal of this study was to determine whether the slowing of atrioventricular (AV) conduction by ATP is caused by ATP per se or is mediated by adenosine formed from ATP degradation. We assessed the effects of ATP, ,B, y-methylene ATP, ADP, AMP, and adenosine on AV conduction time in the isolated perfused guinea pig heart. The cardiac effluent was collected and analyzed for its content of adenine nucleotides and nucleosides. Perfused ATP was rapidly and almost completely broken down to AMP and adenosine; only 2.5 + 0.5% of the infused ATP was recoverable in the effluent. A significant correlation was found between the effluent concentration of adenosine and atria-to-His bundle (A-H) conduction time. Compounds that altered the effect of adenosine on A-H conduction likewise altered the effect of ATP: (1) aminophylline, a competitive antagonist of adenosine, antagonized the ATP-induced A-H prolongation; (2) adenosine deaminase, the enzyme responsible for the deamination of adenosine to inosine, reduced the effect of ATP by 82%; (3) the adenosine transport blockers NBMPR and dipyridamole markedly enhanced the effect of ATP; and (4) EHNA, an inhibitor of adenosine deaminase, potentiated the effect of ATP. Furthermore, the less hydrolyzable ATP analog, /3, y-methylene ATP, was less potent than ATP in causing A-H prolongation. We conclude that the adenosine-like action of ATP on the guinea pig AV node requires that ATP first be degraded to adenosine. Circulation 70, No. 6, 1083-1091, 1984. SINCE early in this century, it has been recognized that adenine nucleotides and adenosine have negative chronotropic and dromotropic effects.'1-These observations have since been confirmed by many other investigators 1 Recently we have demonstrated that (1) the atrioventricular (AV) conduction delay and block caused by adenosine is due solely to a prolongation of the atria-to-His bundle (A-H) interval, (2) the adenosine-induced A-H prolongation is mediated by an extracellular receptor site, (3) aminophylline selectively and competitively antagonizes the adenosine-induced A-H prolongation, (4) nucleoside transport blockers (e.g., dipyridamole) potentiate the AV conduction delay and block caused by adenosine, and (5) although differences exist in the responsiveness of the mammalian AV node to adenosine, adenosine-induced AV Vol. 70, No. 6, December 1984 block can be demonstrated in all the species investigated.8' -1 In man, intravenous administration of adenosine depresses both sinus rate and AV conduction and may be used to terminate some forms of paroxysmal supraventricular tachycardia.'4 Like adenosine, ATP has long been recognized to cause AV block2 4 5 and has recently gained important clinical significance in the management of supraventricular tachycardia."5' 16 The action of ATP appears to be similar to that of adenosine.2'4'6 It has been shown in isolated perfused mammalian heart preparations that ATP, ADP, and AMP are rapidly hydrolyzed to adenosine and inosine.'7-22 Thus the possibility that the AV block caused by ATP is mediated by adenosine must be considered. We sought to determine whether the AV conduction delay and block caused by ATP is due to its own action or that of its degradative product, adenosine.
SINCE early in this century, it has been recognized that adenine nucleotides and adenosine have negative chronotropic and dromotropic effects.'1-These observations have since been confirmed by many other investigators 1 Recently we have demonstrated that (1) the atrioventricular (AV) conduction delay and block caused by adenosine is due solely to a prolongation of the atria-to-His bundle (A-H) interval, (2) the adenosine-induced A-H prolongation is mediated by an extracellular receptor site, (3) aminophylline selectively and competitively antagonizes the adenosine-induced A-H prolongation, (4) nucleoside transport blockers (e.g., dipyridamole) potentiate the AV conduction delay and block caused by adenosine, and (5) although differences exist in the responsiveness of the mammalian AV node to adenosine, adenosine-induced AV
The solution was equilibrated with 95% 02 and 5% CO2. The hearts were placed in a bath filled with Krebs-Henseleit solution. The bath and myocardial temperature were maintained at 350 + 10 C. To facilitate electrical pacing and to expose the region of the AV node, most of the right atrium was excised. The hearts were electrically paced with a pair of Teflon-coated stainless steel wires placed on the left atrium. A Grass model S-4 stimulator provided the stimuli through a stimulus isolation unit as rectangular wave pulses of 3 msec duration and twice threshold intensity at a frequency of 2.5 or 3.0 Hz.
Extracellular electrograms from the left atrium and His bundle were recorded according to techniques previously de- scribed. 8 The following AV conduction times were measured (msec): (1) cycle length (interstimulus interval), (2) A-H interval, defined as the conduction time from the atrial tissue to the bundle of His, (3) H-V interval, defined as the conduction time from the bundle of His to the ventricular myocardium, and (4) AV interval, the atrial to ventricular conduction time.
Adenosine (Sigma), adenosine deaminase Type 1 (Sigma), adenosine 5'-triphosphate (ATP, vanadium-free, Sigma), adenosine 5'-monophosphate (AMP, Sigma), /3, y-methylene adenosine 5'-triphosphate (MeATP, Sigma), atropine (Sigma), S-(p-nitrobenzyl)-6-thioinosine (NBMPR, Aldrich), erythro-9-(2-hydroxy-3-nonyl) adenine HCI (EHNA, gift from Burroughs Wellcome), aminophylline (Invenex), dipyridamole (gift from Boehringer Ingelheim), and propranolol HCl (Sigma) were dissolved in perfusion medium and infused to achieve the desired perfusion fluid concentrations. The purity of adenosine and ATP was determined by reverse-phase high-performance liquid chromotography (HPLC). Adenosine deaminase was dialyzed overnight at 40 C with a Spectrapor membrane (molecular weight cut-off = 6000 to 8000) against MOPS buffer (50 mM, pH 7.5).
Experimental protocols. A 20 to 30 min equilibration period preceded control measurements. Experimental interventions were always preceded and followed by control measurements of AV conduction time, and whenever the precontrol and postcontrol values differed by more than 15%, the intervening experimental data were discarded.
Concentration-response relationship for adenosine and adenine nucleotides. In seven hearts the effects on AV conduction time of two concentrations (7 x 10-6M and 1 x 10-5M) of adenosine, AMP, ADP, ATP, and MeATP were investigated. The order of infusion of the compounds varied from heart to heart, but each heart was exposed to adenosine and its four phosphorylated derivatives; the order of infusion did not alter the response. The data are expressed as the difference between intervention and control, i.e., the increment in the A-H interval caused by each compound.
Interventions that modify the effects of adenosine. Interventions known to attenuate or potentiate the actions of adenosine on AV conduction time were examined in 27 hearts.
Aminophylline (a competitive antagonist of adenosine) and adenosine deaminase (the enzyme responsible for the deamination of adenosine to inosine) were used to attenuate the effects of adenosine. Conversely, dipyridamole and NBMPR (inhibitors of adenosine uptake) and EHNA (an inhibitor of adenosine deaminase) were used to potentiate the effects of adenosine.
The protocol for the aminophylline experiments is depicted in figure 1 . A similar protocol was followed when other compounds were studied. This protocol permits comparison of the effects of adenosine, ATP, and the interventions (e.g., aminophylline) alone, as well as in combination.
Effluent concentration of adenosine and ATP vs A-H interval Adenosine. In a separate series of experiments, effluent samples from the hearts were collected simultaneously with mea-
(ATP Washout) FIGURE 1. Summary of the experimental protocol. The above steps were carried out consecutively. The order of infusion of adenosine and ATP varied for each heart, i.e., some hearts received adenosine first and ATP second and vice versa. The same protocol applies to the dipyridamole (figure 6) and EHNA (figure 7) experiments. The duration of each period of drug infusion was 5 min; each washout period was of 10 min duration. All electrophysiologic measurements and effluent samples were obtained at the end of each period.
surements of AV conduction times. The adenosine, inosine, and hypoxanthine contents of the effluents were determined. The protocol used in these experiments differed from that depicted in figure 1 as follows: (1) the infusion of ATP preceded adenosine to avoid contamination of the effluent with residual adenosine during ATP infusion; (2) the A-H measurements and the collection of effluent samples were obtained at least 5 min after starting or stopping the infusion of adenosine, ATP, and dipyridamole. Samples of 8 ml of the effluent were collected in the last minute (i.e., 4 to 5 min) of each step (intervention) of the sequence. The sample was divided into aliquots of 4 ml each and stored (less than 2 weeks) at -800 C until analyzed.
ATP. In another group of five hearts effluent samples were collected for determination of ATP (and its degradative products). Control A-H measurements and an effluent sample were obtained at the end of a 30 min equilibration period. After the control period, ATP (perfusate concentration 5 X 10-6M) was infused for 5 min; an effluent sample was obtained and the A-H interval was measured. Ten minutes after the infusion of ATP was stopped, a postcontrol effluent sample was collected and A-H measurements were obtained. The effluent samples (4 ml) for ATP analysis were collected in tubes containing 5 ml of 100% methanol. Effluent samples (4 ml) for analysis of adenosine were collected as described above for the previous group. Nucleoside and nucleotide analysis Nucleoside. Each 4 ml aliquot of perfusate was blow-dried with air at 370 C and then reconstituted in 1 ml of distilled water.
All samples were filtered (pore size 0.22 gm, Millipore) before assay by HPLC. This method of sample preparation resulted in an overall average recovery of adenosine of 99 + 0.8% (mean + SEM of eight effluent samples), as determined with known adenosine standards.
The HPLC system consisted of Waters Associates models M-45 and 6000A pumps, a 720 system controller, a WISP model 710-B autoinjector, a model 440 fixed-wavelength ultraviolet detector (254 nm), a Hewlett-Packard 3390A integrator, and a Heath model SR-205 recorder. An Altex Ultrasphere ODS 4.6 mm id x 25 cm column was used to separate the nucleosides. Nucleoside separation was obtained by using linear gradient elution from 100% of 2% methanol (Burdick and Jackson) in water with 20 mM KH2PO4, pH 5.6, to 100% of 22% methanol in water, 20 mM KH2PO4, pH 5.6, for 30 min at a flow rate of 1 ml/min.23 Quantitation was by peak height.
Nucleotide. Each 9 ml volume of perfusate in methanol was blow-dried at room temperature and then reconstituted in 1 ml of distilled water. The samples were filtered (pore size 0.22 LABORATORY INVESTIGATION-ELECTROPHYSIOLOGY of ATP was slightly lower (64 + 2%) but not significantly different from control (p > .05).
A Dupont Zorbax NH2 4.6 mm id x 25 cm column was used to separate the nucleotides. Nucleotide separation was achieved by using linear gradient elution from 100% of 5 mM NH4PO4, pH 4, to 100% of 750 mM NH4PO4, pH 4, for 30 min at a flow rate of 1.6 ml/min. Sulfonic acid was used for titrating buffers. Nucleotide peak heights were measured and quantitated by comparison with standards.
Purity of ATP, adenosine, and inosine used for perfusion. We determined the degree of contamination of the ATP, adenosine, and inosine solutions with their degradation products.
From HPLC analysis at 254 nm it was determined that ADP was present at 1% of the ATP content in perfused ATP samples (vanadium-free) and AMP was present as a 0.03% contaminant. Adenosine, inosine, and hypoxanthine were not present in detectable quantities in the lot of ATP (i.e., less than one part in 50,000).
Contamination of the adenosine and inosine solutions by other compounds that absorb at 254 nm was determined to be less than 0.1%.
Data analysis. Statistical analysis was based on Student's t distribution for paired (intervention vs average precontrol and postcontrol) data. Linear regression analysis was used to determine the correlation between the effluent concentration of adenosine and prolongation of the A-H interval. The A-H values during second-degree heart block were not included in the statistics or means. All data are expressed as means + SEM. Differences were considered significant when p < .05.
Results
Concentration-response relationship for adenosine and adenine nucleotides. The control values for A-H and H-V intervals averaged 34 + 2 and 12 ± 1 msec, respectively, in seven hearts. The precontrol and postcontrol A-H conduction times did not differ by more than 2 to 4 msec. Significant prolongation of the AV conduction time was observed with each of the substances tested except for the lower concentration of MeATP (figure 2).
The prolongation of the AV conduction time caused by adenosine and adenine nucleotides was due to an increase of the A-H interval. The H-V interval remained unchanged at 12 ± 1 msec. As shown in figure 2, adenosine and the adenine nucleotides induced a dose-dependent lengthening of the A-H interval; adenosine was the most potent and MeATP the least. ATP, ADP, and AMP were equipotent. Adenosine at 7 x 10-6M produced second-degree AV block in three of seven hearts, and third-degree AV block was observed in all hearts at 10-5M. None of the other compounds caused second-degree AV block at the concentrations studied. The A-H prolongation was rapidly (<3 min) reversed upon washout. In three separate hearts, inosine was infused to achieve a final perfusate concentration of 2 x 10-4M. Inosine did not cause a significant change in AV conduction time, i.e., during the control period the A-H interval was 37 ± 2 msec and 5 min Interventions that modify the effects of adenosine
Aminophylline. The effects of 3 X 10-5M aminophylline on the adenosine-and ATP-induced A-H prolongation were studied in hearts treated with 10-6M propranolol. Since methylxanthines are known to release catecholamines from nerve terminals,' propranolol was used to block the effects of endogenous catecholamines on AV conduction in the experiments involving aminophylline. Propranolol by itself had no significant effect on the A-H interval and did not alter the response of the hearts to either adenosine or ATP.
As illustrated in figure 3, aminophylline (3 x 10 5M) completely antagonized the A-H prolongation caused by 7 x 10-6M adenosine and 9.5 x 10-6M ATP. The same concentration of aminophylline alone did not cause any significant change in the A-H interval (figure 3). In three additional hearts paced at 3 Hz and to which higher doses of adenosine (2 x 10-5M) and ATP (3 x 10 5M) were administered, secondand third-degree AV block ensued (not shown). Aminophylline (3 x 10-5M) effectively reversed the AV block caused by both adenosine and ATP (not shown).
Adenosine deaminase. A-H prolongation is illustrated in figure 4 . As can be seen, 9.5 X 10-6M ATP (panel B) caused a 10 msec prolongation of the A-H interval, whereas 7 x 10-6M adenosine (panel B') increased the A-H interval by 16 msec. In contrast, 7 min after the addition of 5 U/ml adenosine deaminase to the perfusate (panels C and C') the same concentrations of ATP and adenosine had no significant effect on the A-H interval. Similar results were obtained in nine hearts ( figure 5 ). The control A-H and H-V values in this group were 36 ± 1 and 11 ± 1 msec, respectively. ATP (9.5 x 106M) caused an 11 + 1 msec increase in the A-H interval, whereas 7 X 10-6 adenosine prolonged the A-H interval by 18 + 1.5 msec. In the presence of adenosine deaminase the same concentrations of ATP and adenosine prolonged the A-H interval by 2 ± 0.5 and 1.5 + 0.5 msec, respectively. Thus adenosine prolonged the A-H interval significantly more than did ATP in the absence of adenosine deaminase. However, in the presence of adenosine deaminase the changes in the A-H interval induced by ATP or adenosine were not significant. In five other hearts adenosine deaminase prevented the ATP and adenosine-induced second-degree AV block produced by higher doses of ATP (3 X 10-5M) and adenosine (2 x 10-5M) (not shown). Adenosine deaminase by itself caused, in general, a small (2 to 3 msec) but insignificant shortening of the A-H interval. Inosine in concentrations up to 2 X 10 4M did not cause any change in the A-H or H-V intervals.
The ability of adenosine deaminase to prevent the A-H prolongation induced by AMP was also investigated. AMP (9 x 10-M) prolonged the A-H interval by an average of 13 ± 3 msec (n = 3). The same concentration of AMP perfused with 5 U/ml adenosine deaminase prolonged the A-H interval by only 2.5 ± 0.5 msec (n = 3).
Nucleoside transport blockers. Prolongation of the AV conduction time by adenosine and ATP was investigated in preparations treated with the nucleoside transport blockers dipyridamole (5 x 10-7M) and NBMPR (5 X 10-M). Figure 6 illustrates the effects of 3 x 10 -7M adenosine and ATP in the absence and presence of 5 x 10 7M dipyridamole. Note that at a concentration of 3 x 10-7M neither adenosine nor ATP increased the A-H interval. Dipyridamole alone caused a small (2 to 4 msec) and insignificant (p > .05) prolongation of the A-H interval. However, when dipyridamole was combined with adenosine or ATP, a marked prolongation of the A-H interval occurred. The combination of dipyridamole with adenosine resulted in a significantly (p < .05) greater increase in the A-H interval than the combination of dipyridamole and ATP. Higher concentrations of ATP or adenosine (e.g., 5 X 10-6M) with dipyridamole resulted in second-and third-degree AV block (see below). Although diminished, the potentiating action of dipyridamole persisted even after 30 to 40 min of washout.
In two other preparations the nucleoside transport blocker NBMPR (5 x 10-8M) was found to potentiate the effects of ATP and adenosine. In the presence of 5 x 10-8M NBMPR, 7 x 10-M adenosine and 1.5 x 10 -7M ATP prolonged the A-H interval by 12 and 10 msec, respectively. NBMPR alone did not significantly prolong the A-H interval. and to correlate the adenosine concentration in the effluent (as a result of adenosine and ATP infusion) with the AV conduction times. These findings are summarized in tables 1 and 2. In six guinea pig hearts the basal effluent adenosine concentration was 18 + 3 nM and the concentrations of inosine and hypoxanthine were 105 + 34 and 57 ± 27 nM, respectively. When ATP was infused (nominal concentration 5 ,M; measured concentration 4.52 ,M) over 61% of the infused ATP was recovered as AMP, adenosine, inosine, and hypoxanthine. Virtually none of the infused ATP was recovered intact. AMP, adenosine, inosine, and hypoxanthine levels reached 1445 + 103, 1042 + 63, 230 ± 42, and 62 + 14 nM, respectively. The remaining 39% of the infused ATP was either taken up by the heart or metabolized to a compound that we did not measure. Concomitant with this significant rise in the effluent concentration of adenosine, the A-H interval was prolonged by 9 ± 1 msec. , and 25% was taken up by the heart. Associated with the rise in the effluent concentration of adenosine was a prolongation of the A-H interval by 21 + 2 msec and the development of second-degree AV block in two of six hearts. Five minutes after the infusion of adenosine was stopped, both the A-H interval and the concentration of adenosine in the effluent returned to control levels. For the remaining part of the experiment (table 1) , 5 x 10-7M dipyridamole was added to the perfusion solution and the infusions of ATP and adenosine were repeated. Dipyridamole alone caused a small increase in the effluent concentration of adenosine and the A-H interval was lengthened by 3 ± 1 msec (p < .05). However, when 5 x 10-6M ATP was added to the perfusate the effluent concentration of adenosine rose to a significantly higher level than that observed in the absence of dipyridamole, and second-degree AV block occurred in three of five hearts. Washout of ATP resulted in a sharp decline in the effluent adenosine level and prompt resumption of 1:1 AV conduction. During infusion of adenosine to reach a perfusate level of 5 x 1088 10-6M in the continued presence of dipyridamole, all of the infused adenosine was recovered in the effluent. The high effluent adenosine concentrations were accompanied by third-degree AV block in all hearts. After stopping the infusion of adenosine the effluent concentration of adenosine fell to 243 ± 104 nM. This effluent level of adenosine was significantly higher than the control and previous washouts (i.e., recovery was not complete). Similarly, the A-H interval failed to return to control levels.
As shown in figure 8 , a significant correlation (r .89) between the effluent level of adenosine and the A-H interval was found, i.e., the greater the effluent concentration of adenosine, the longer the A-H interval. This correlation held true irrespective of the experimental conditions, i.e., during control or with adenosine and ATP alone or combined with dipyrida- Table 2 summarizes the data obtained in a separate series of five hearts, in which a stock solution of ATP was infused at a rate to produce a perfusate concentration of 5 ,M. The perfused ATP was almost completely dephosphorylated to AMP and adenosine (table 2) . The sum of the nucleotides and nucleosides measured was 3614.3 ± 17 nM, i.e., 72% of the total ATP infused. Most of the unrecovered 28% appears to have been taken up by the heart. The A-H interval was prolonged by 6 + 1 msec during the infusion of ATP.
Discussion
Previous work has shown that both adenine nucleotides and adenosine cause AV conduction block. '-8 Because ATP can be rapidly broken down into AMP, and AMP in turn to adenosine, we have investigated the possibility that the negative dromotropic effect of adenine nucleotides is mediated by adenosine. We found that (1) aminophylline, a competitive antagonist of adenosine,12 25, 26 antagonized the effect of ATP on AV conduction time, (2) [Adenosine] nM FIGURE 8. Correlation between changes in A-H interval and adenosine concentration in the effluent from isolated guinea pig hearts. The A-H increments (msec) were obtained by subtracting the values for A-H interval (msec) obtained during interventions from the control A-H value (37 msec) of this group. The correlation is significant irrespective of the intervention (i.e., adenosine, ATP, dipyridamole, etc.; see text). Not included in the analysis are trials in which the interventions caused second-or third-degree heart block. Second-degree AV block occurred in four of eight hearts at an effluent adenosine concentration 2 1600 nM and in all except one heart at an adenosine concentration 2 3000 nM.
by 82% and 81% the effects of ATP and AMP, respectively, (3) the less hydrolyzable ATP analog MeATP was significantly less potent in causing A-H prolongation than ATP, (4) the adenosine transport blockers dipyridamole and NBMPR markedly potentiated the effects of ATP, and (5) EHNA, an inhibitor of adenosine deaminase, significantly enhanced the effect of ATP on AV conduction. Furthermore, both ATP and 
